These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30198875)

  • 1. Huntington's Disease and Employment: The Relative Contributions of Cognitive and Motor Decline to the Decision to Leave Work.
    Watkins K; Purks J; Kumar A; Sokas RK; Heller H; Anderson KE
    J Huntingtons Dis; 2018; 7(4):367-377. PubMed ID: 30198875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease.
    Zielonka D; Ren M; De Michele G; Roos RAC; Squitieri F; Bentivoglio AR; Marcinkowski JT; Landwehrmeyer GB
    Parkinsonism Relat Disord; 2018 Apr; 49():42-47. PubMed ID: 29326033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
    Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
    J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characteristics of late-onset Huntington's disease.
    Oosterloo M; Bijlsma EK; van Kuijk SM; Minkels F; de Die-Smulders CE
    Parkinsonism Relat Disord; 2019 Apr; 61():101-105. PubMed ID: 30528461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survey of the Huntington's Disease Patient and Caregiver Community Reveals Most Impactful Symptoms and Treatment Needs.
    Simpson JA; Lovecky D; Kogan J; Vetter LA; Yohrling GJ
    J Huntingtons Dis; 2016 Dec; 5(4):395-403. PubMed ID: 27983566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of functional decline in Huntington's disease. Huntington Study Group.
    Marder K; Zhao H; Myers RH; Cudkowicz M; Kayson E; Kieburtz K; Orme C; Paulsen J; Penney JB; Siemers E; Shoulson I
    Neurology; 2000 Jan; 54(2):452-8. PubMed ID: 10668713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Decline: Visualising Progression in Huntington's Disease using a Clinical Dashboard with Enroll-HD Data.
    Walker T; Ghosh B; Kipps C
    J Huntingtons Dis; 2017; 6(2):139-147. PubMed ID: 28550266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis.
    Ranganathan M; Kostyk SK; Allain DC; Race JA; Daley AM
    Clin Genet; 2021 Jan; 99(1):133-142. PubMed ID: 33020896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Age of Onset on Huntington's Disease Phenotype.
    Kwa L; Larson D; Yeh C; Bega D
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():21. PubMed ID: 32775035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive decline in Huntington's disease expansion gene carriers.
    Baake V; Reijntjes RHAM; Dumas EM; Thompson JC; ; Roos RAC
    Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of Working Capacity Changes Related to Huntington's Disease: A Longitudinal Study.
    van der Zwaan KF; Jacobs M; van Zwet EW; Roos RAC; de Bot ST
    J Huntingtons Dis; 2021; 10(2):269-276. PubMed ID: 33523014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
    Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
    Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific cognitive theory of mind and behavioral dysfunctions in early manifest Huntington disease: a case report.
    Caillaud M; Laisney M; Bejanin A; Scherer-Gagou C; Bonneau D; Duclos H; Eustache F; Verny C; Desgranges B; Allain P
    Neurocase; 2020 Feb; 26(1):36-41. PubMed ID: 31771445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.
    Aldaz T; Nigro P; Sánchez-Gómez A; Painous C; Planellas L; Santacruz P; Cámara A; Compta Y; Valldeoriola F; Martí MJ; Muñoz E
    J Neurol; 2019 Jun; 266(6):1340-1350. PubMed ID: 30834978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural abnormalities contribute to functional decline in Huntington's disease.
    Hamilton JM; Salmon DP; Corey-Bloom J; Gamst A; Paulsen JS; Jerkins S; Jacobson MW; Peavy G
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):120-2. PubMed ID: 12486282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of motor subtypes in Huntington's disease: a 6-year follow-up study.
    Jacobs M; Hart EP; van Zwet EW; Bentivoglio AR; Burgunder JM; Craufurd D; Reilmann R; Saft C; Roos RA;
    J Neurol; 2016 Oct; 263(10):2080-5. PubMed ID: 27435968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease.
    Van Liew C; Gluhm S; Goldstein J; Cronan TA; Corey-Bloom J
    Psychiatry; 2013; 76(4):323-35. PubMed ID: 24299091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and Motor Norms for Huntington's Disease.
    Mills JA; Long JD; Mohan A; Ware JJ; Sampaio C
    Arch Clin Neuropsychol; 2020 Aug; 35(6):671-682. PubMed ID: 32407458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study.
    Gonzalez V; Cif L; Biolsi B; Garcia-Ptacek S; Seychelles A; Sanrey E; Descours I; Coubes C; de Moura AM; Corlobe A; James S; Roujeau T; Coubes P
    J Neurosurg; 2014 Jul; 121(1):114-22. PubMed ID: 24702329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.